Atrys Health, S.A. (BME:ATRY)
Spain · Delayed Price · Currency is EUR 2.655
-0.005 (-0.19%)
Aug 7, 2026, 12:16 PM CET
Atrys Health Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 13.07 | 20.37 | 41.83 | 34.3 | 35.13 |
Cash & Short-Term Investments | 13.07 | 20.37 | 41.83 | 34.3 | 35.13 |
Cash Growth | -35.84% | -51.31% | 21.97% | -2.37% | 101.00% |
Accounts Receivable | 29.27 | 51.38 | 44.63 | 114.36 | 109.64 |
Other Receivables | 3.52 | 2.56 | 4.4 | 3.76 | 3.63 |
Total Trade Receivables | 32.79 | 53.94 | 49.02 | 118.12 | 113.27 |
Inventory | 2.24 | 1.57 | 1.68 | 1.21 | 0.79 |
Other Current Assets | 181.18 | 13.3 | 4.75 | 8.56 | 10.55 |
Total Current Assets | 233.96 | 89.18 | 100.87 | 101.87 | 103.11 |
Net Property, Plant & Equipment | 43.72 | 58.17 | 62.48 | 69.33 | 62.54 |
Other Intangible Assets | 75.63 | 424.09 | 174.75 | 731.59 | 151.13 |
Goodwill | 132.45 | - | 275.74 | 306.21 | 235.84 |
Long-Term Investments | 0 | 0 | 0.01 | 0 | 0.01 |
Other Long-Term Assets | 5.88 | 12.76 | 9.84 | 13.94 | 13.01 |
Total Assets | 494.04 | 584.19 | 629 | 704.05 | 565.63 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 26.51 | 25.36 | 22.28 | 57.27 | 43.57 |
Accrued Expenses | 3.58 | 7.21 | 8.38 | 7.45 | 11.49 |
Current Portion of Long-Term Debt | 223.18 | 60.17 | 65.17 | 28.73 | 24.33 |
Current Portion of Leases | - | 5.82 | - | - | - |
Other Current Liabilities | 37.14 | 1.23 | 7.82 | 53.84 | 31.81 |
Total Current Liabilities | 290.42 | 99.79 | 103.64 | 100.56 | 71.5 |
Long-Term Debt | 12.35 | 170.41 | 162.73 | 281.13 | 208.95 |
Long-Term Leases | - | 25.52 | - | - | - |
Other Long-Term Liabilities | 39.31 | 35.23 | 72.75 | 126.58 | 115.68 |
Total Long-Term Liabilities | 51.66 | 231.17 | 235.48 | 267.15 | 220.15 |
Total Liabilities | 342.08 | 330.95 | 339.12 | 367.71 | 291.65 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.76 | 0.76 | 0.76 | 1.52 | 1.23 |
Treasury Stock | -0.32 | -0.32 | -0.29 | -0.75 | -0.48 |
Additional Paid-in Capital | 420.05 | 420.05 | 420.05 | 420.05 | 315.5 |
Accumulated Other Comprehensive Income | -8.3 | -7.74 | -3.13 | -2.17 | 6.44 |
Retained Earnings | -260.33 | -159.65 | -127.52 | -81.5 | -48.05 |
Total Common Shareholders' Equity | 303.72 | 253.1 | 579.74 | 672.79 | 548.06 |
Minority Interest | 0.1 | 0.14 | 0.01 | -0.06 | -0.05 |
Shareholders' Equity | 151.96 | 253.24 | 289.88 | 336.34 | 273.98 |
Total Liabilities & Equity | 494.04 | 584.19 | 629 | 704.05 | 565.63 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 235.53 | 261.92 | 227.9 | 309.86 | 233.28 |
Net Cash (Debt) | -222.47 | -241.55 | -186.07 | -275.57 | -198.16 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -2.64 | -2.95 | -2.41 | -3.91 | -3.70 |
Book Value | 303.72 | 253.1 | 579.74 | 672.79 | 548.06 |
Book Value Per Share | 3.61 | 3.09 | 7.50 | 9.55 | 10.24 |
Tangible Book Value | 95.65 | -170.99 | 129.26 | -365.01 | 161.09 |
Tangible Book Value Per Share | 1.14 | -2.09 | 1.67 | -5.18 | 3.01 |